Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine

By Jertborn M.   &   9hren C.   Holmgren J.   Svennerholm A.-M.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 255-260

Elsevier

Access to resources Recommend Favorite

Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (WC/rBS) oral cholera vaccine in Peru

By Begue R.E.   Castellares G.   Ruiz R.   Hayashi K.E.   Sanchez J.L.   Gotuzzo E.   Oberst R.B.   Taylor D.N.   Svennerholm A.-M.  

Vaccine, Vol. 13, Iss. 7, 1995-01 ,pp. : 691-694

Elsevier

Access to resources Recommend Favorite

Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine

By Lebens M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1299-1299

Elsevier

Access to resources Recommend Favorite

Suppressive effect of zinc on antibody response to cholera toxin in children given the killed, B subunit-whole cell, oral cholera vaccine

By Qadri F.   Ahmed T.   Wahed M.A.   Ahmed F.   Bhuiyan N.A.   Rahman A.S.M.H.   Clemens J.D.   Black R.E.   Albert M.J.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 416-421

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

By Halperin S.A.   Smith B.   Mabrouk T.   Germain M.   Trepanier P.   Hassell T.   Treanor J.   Gauthier R.   Mills E.L.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1240-1247

Elsevier

Access to resources Recommend Favorite